A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.

NCT01347710 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

795

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Flurpiridaz F18
DRUG: 99mTechnicium (sestamibi or tetrofosmin)

Sponsor

Lantheus Medical Imaging